Stephen B Kahl
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.7MFederal grants as PI3 awards
1Patents grantedLatest Feb 13, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 20, 2025 | NIH | SBIR Phase II Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer | $1.1M | MANZANITA PHARMACEUTICALS, INC. |
| Sep 6, 2024 | NIH | SBIR Phase II Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer | $906K | MANZANITA PHARMACEUTICALS, INC. |
| Aug 23, 2018 | NIH | SBIR Phase II Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent | $753K | MANZANITA PHARMACEUTICALS, INC. |
2 patents as inventor
- US 11897928MANZANITA PHARMACEUTICALS, INC.Feb 13, 2024
- US MANZANITA PHARMACEUTICALS, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#773
Awards as PI#927
Patents#284
Companies
- MANZANITA PHARMACEUTICALS, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.